-
US Retail Sales and Fed Minutes Set Up a Critical Test for Consumers
-
Kansas City Fed Chief Says Inflation Is Still Running Too Hot
-
Oil Heads for Second Weekly Loss as Supply Surplus Emerges
-
Asian Markets Slide as AI Concerns Hit Chip Stocks
-
Brazil Faces Debt and Inflation Test as Lula Prepares Fourth Term
-
Canada Signals Openness to Chinese Automakers if US Trade Talks Fail
-
Archive of Our Own Restores Service After Weeks-Long Security Shutdown
-
Canada Expands Asian Trade Push as US Negotiations Resume
-
US Mortgage Rate Falls for Fourth Week but Remains Above 7%
-
US Jobless Claims Rise to 200,000 but Layoffs Remain Historically Low
-
Fire Erupts Near MetLife Stadium After Jets-Bills Game
-
Italy Raises 2026 Growth View but Warns Energy Will Keep Inflation High
-
Euro-Area Growth Slows to 0.4% While Employment Stalls
-
UK Economy Grows 0.7% in Third Quarter as Services Lead Expansion
-
US Wholesale Inflation Eases Monthly but Hits a Four-Year Annual High
-
India's Retail Inflation Reaches 6.09% as Food Prices Accelerate
-
India's Wholesale Inflation Jumps to 12.29% as Fuel Costs Surge
-
China's October Activity Data Reveal a Weak Start to the Fourth Quarter
-
Japan's Economy Edges Into Contraction as Costly Oil Weighs on Demand
-
Philippines Urges ASEAN and China to Accelerate South China Sea Code of Conduct
-
South Korea Launches Probe into NewJeans Contract Controversy
-
Met Office Issues Yellow Snow Warning for Nottinghamshire on Tuesday
-
UK Defence Secretary Warns Russia Nukes Not for Negotiation as HMS Vengeance Returns
-
NuRAN Wireless Eliminates Floating-Price Preferred Overhang and Locks In a Fixed C$1.20 Conversion Price
-
SMX: The Future of Gold Will Be Defined by What We Know About It -Powering Verified Trade and Tokenisation
-
Cardiff Lexington Announces Third Quarter 2026 Financial Results
-
Aptevo Provides 3Q26 Business Update Highlighting Growing Momentum for Mipletamig and Reports Third Quarter Financial Results
-
Expecting a Refund but Owe Back Taxes? Clear Start Tax Explains How the IRS Offset Program Takes It First
-
MicroVision Lidar Powers Commercial Driverless Trucking at Scale with Kodiak AI
-
Rescue Intellitech Expands Professional Decontamination Portfolio for Fire Departments with DeconWasher(TM) Pro S
-
Westell Technologies, Inc. Announces Its Commencing a Tender Offer
-
SMX Brings a New Level of Transparency to Gold Trading Through trueGold Technology
-
Ainos Reports Third Quarter 2026 Results and Highlights Expanding AI Nose Commercial Momentum
-
Wi2Wi Reports 35% Revenue Growth to US$2.36M and Returns to Profitability with US$268K Net Income in Q3 2026
-
Sharecare Partners With HomeTown Health to Bring AskMD, Funded Through the GREAT Health Program, to More Rural Hospitals and Patients Across Georgia
-
Gladstone Capital Corporation Earnings Call and Webcast Information
-
NWPG's NFI Empire Reports Third Quarter 2026 Results
-
GameSquare Holdings Reports 2026 Third Quarter Results with Revenue up 77% YoY and Net Income Reaches $10.1 Million
-
ValorPay UAB Goes Live on T2, the Eurosystem's Real-Time Settlement System
-
CNS Pharmaceuticals Reports Third Quarter 2026 Financial Results and Highlights Progress in Establishing Transformative Therapeutic Pipeline
-
XCF Global Reports Third Quarter 2026 Financial Results & Affirms 2027 Outlook
-
NextSource Materials Appoints Eugene Lee as Chief Financial Officer
-
International Battery Metals Ltd. Reports Second Quarter of Fiscal Year 2027 Financial Results
-
Abasca Resources Engages Northern Arc Public Affairs to Advance Federal Engagement on the Loki Flake Graphite Project
-
AsiaFIN Holdings Corp. Announces Third Quarter 2026 Results, Reporting Strong Nine-Month Financial Performance with Improved Margins
-
Thalia Therapeutics PLC Announces Promising Interim Phase I Data for miRisten in AML
-
Strategic Metals Reports Promising Results From the Rusty and Ranch Projects
-
Golden Minerals Reports Third Quarter 2026 Financial Results
-
OBI Pharma Signs Collaboration and License Agreement with Novartis
-
InterContinental Hotels Group PLC Announces Transaction in Own Shares - November 16
Agronomics Invests AU$3m in All G & Issue of Equity
Agronomics invests AU$3 million in All G, Issue of Equity and TVR
DOUGLAS, ISLE OF MAN / ACCESS Newswire / January 15, 2026 / Agronomics (LSE:ANIC) announces an additional investment of AU$3 million in its portfolio company, All G Co Holdings Pty Limited ("All G"), an Australian biotech specialising in precision fermentation of human and bovine milk proteins, notably lactoferrin. This technology enables the production of lactoferrin without the use of animals, supporting advancements in nutrition, sustainability, and health.
All G's lactoferrin is cost-effective and environmentally sustainable, suitable for applications in infant and clinical nutrition, functional foods, skincare, and animal nutrition. The company has achieved significant milestones and in November 2024, All G became the first company globally to receive regulatory clearance for the sale of recombinant bovine lactoferrin in China. In January 2025, the company achieved self-affirmed Generally Recognised as Safe status for its animal free animal‑free bovine lactoferrin in the US. In July, All G announced plans to launch lactoferrin in the US and China during Q1 2026.
The new funding will support commercial-scale production, regulatory submissions, patent development, and business expansion in Asia and Europe.
Note Purchase Agreement
Agronomics will invest the AU$ 3 million (c. £1,468,860) via a Note Purchase Agreement ("NPA") as part of a minimum AU$10 million funding round, with notes issued pursuant to a Convertible Note Instrument ("Instrument"). Notes issued pursuant to the Instrument ("Notes") have a 24 month maturity period and are issued with a coupon of 6% per annum. The Notes are convertible into new shares of All-G subject to All-G completing a qualifying fundraise during the term of the Notes. The conversion discount is 20% if a qualifying financing or exit occurs within 18 months, or a 30% conversion discount if a qualifying financing or exit occurs after 18 months. If no qualifying financing or exit occurs within 24 months, the NPA is redeemable, unless 75% of the NPA holders elect conversion.
The consideration due from Agronomics under the Note Purchase Agreement will be satisfied in full by the issue of 10,026,375 new Ordinary Shares of the Company, each new share issued at a price equal to 14.65 pence (being the net asset value per share as at 30 September 2025).
Following this transaction, Agronomics' total investment in All G will be approximately £8.9 million, representing about 4.99% of the Company's reported NAV of £147.8 million.
TVR
Application has been made for the new shares to be admitted to trading on AIM, with admission expected on 21 January 2026. Post-admission, the Company's issued share capital will total 1,056,575,208 Ordinary Shares, all with voting rights. The Company does not hold any Ordinary Shares in Treasury. Shareholders should therefore use 1,056,575,208 as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the Financial Conduct Authority's Disclosure and Transparency Rules.
This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) No. 596/2014, as it forms part of UK Domestic Law by virtue of the European Union (Withdrawal) Act 2018. Upon the publication of this announcement, this inside information is now considered to be in the public domain.
About All G
All G is a Sydney-based biotechnology company that is at the forefront of precision fermentation, developing high-value, human and bovine milk proteins for use in functional foods, medical nutrition and infant nutrition. Learn more at www.allg.com.
About Agronomics
Agronomics is a leading London-listed company focused on investment opportunities within the field of cellular agriculture. The Company has established a portfolio of over 20 companies developing technologies that produce food and materials historically derived from animals, offering solutions for improved sustainability, human health, and food security.
A full list of Agronomics' portfolio companies is available at www.agronomics.im.
For further information, please contact:
Agronomics Limited | Beaumont Cornish Limited | Cavendish Capital Markets Limited | Canaccord Genuity Limited | 33Seconds Limited |
The Company | Nomad | Joint Broker | Joint Broker | Public Relations |
Jim Mellon | Roland Cornish | Giles Balleny | Andrew Potts | Jack Ferris |
+44 (0) 1624 639396 | +44 (0) 207 628 3396 | +44 (0) 207 397 8900 | +44 (0) 207 523 8000 |
Nominated Adviser Statement
Beaumont Cornish Limited ("Beaumont Cornish"), is the Company's Nominated Adviser and is authorised and regulated in the United Kingdom by the Financial Conduct Authority. Beaumont Cornish's responsibilities as the Company's Nominated Adviser, including a responsibility to advise and guide the Company on its responsibilities under the AIM Rules for Companies and AIM Rules for Nominated Advisers, are owed solely to the London Stock Exchange. Beaumont Cornish is not acting for and will not be responsible to any other persons for providing protections afforded to customers of Beaumont Cornish nor for advising them in relation to the proposed arrangements described in the announcement or any matter referred to in it.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
SOURCE: Agronomics Limited
View the original press release on ACCESS Newswire
A.Malone--AMWN